[H]C12CC([H])(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4([H])C(O)C(C)=CC([H])(C(=O)O1)C34O)OC1(C=CC(C)C([H])(C(C)C)O1)C2.[H]C12CC([H])(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4([H])C(O)C(C)=CC([H])(C(=O)O1)C34O)OC1(C=CC(C)C([H])(C(C)CC)O1)C2
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?